$CTYX DD THREAD!
Lots of good DD out there, but I want to cover a few specifics: the CEO (solid gold imo), type of company that is coming, why it should be very lucrative, and the specific company it might be. Public Float only 188,707,258 as of 12/31/19
https://www.connectyx.com/ ">https://www.connectyx.com/">...
Lots of good DD out there, but I want to cover a few specifics: the CEO (solid gold imo), type of company that is coming, why it should be very lucrative, and the specific company it might be. Public Float only 188,707,258 as of 12/31/19
https://www.connectyx.com/ ">https://www.connectyx.com/">...
$CTYX Paul M Michaels is the CEO of Sunmed and the interim CEO of Connectyx. He co-founded Nobelpharma, and completed transactions with other global pharmaceutical companies such as Celgene, Sumitomo, Teva, ICOS, Neurocrine, Cell Therapeutics, and Gilead. https://www.linkedin.com/in/paul-m-michaels">https://www.linkedin.com/in/paul-m...
$CTYX is a global biomedical company that seeks to develop, license, and market Pharmaceuticals and Medical Devices targeting FDA-defined "Orphan Diseases" with patient populations under 200,000 in the US. Paul M Michaels has the experience to do this.
https://www.otcmarkets.com/stock/CTYX/profile">https://www.otcmarkets.com/stock/CTY...
https://www.otcmarkets.com/stock/CTYX/profile">https://www.otcmarkets.com/stock/CTY...
$CTYX FDA-defined "Orphan Diseases" are a very lucrative market space. A rough estimate would be 400m people worldwide - 30m in Europe and 25m in the US. Plus there are extremely generous financial incentives offered by governments and little competition. https://pharmaboardroom.com/articles/enthusiasm-for-orphan-drugs-is-here-to-stay/">https://pharmaboardroom.com/articles/...
$CTYX Considering CEO Paul M Michaels& #39; background & the Connectyx company profile, I think the best fit is Nobelpharma America, who specializes in "Neglected Pharmaceuticals and Medical Devices." Recall that Mr. Michaels co-founded Nobelpharma in Japan!!!
https://www.nobelpharma-us.com/ ">https://www.nobelpharma-us.com/">...
https://www.nobelpharma-us.com/ ">https://www.nobelpharma-us.com/">...
$CTYX Nobelpharma America was incorporated in DE on 6/3/19. SunMed Advisors recently acquired control of Connectyx via purchase of preferred stock. The Connectyx securities counsel is Jonathan D. Leinwand, who specializes in mergers. Everything fits, imo. https://www.globenewswire.com/news-release/2020/03/06/1996536/0/en/Connectyx-Technologies-Holdings-Group-announces-Shareholder-Update.html">https://www.globenewswire.com/news-rele...
$CTYX Nobelpharma America is a new company, but the parent company in Japan was projecting sales of approximately $116,553,728.09 USD for 2019, with net profit of $8,786,244.49 USD
https://www.nobelpharma.co.jp/en/financial/index.html">https://www.nobelpharma.co.jp/en/financ...
https://www.nobelpharma.co.jp/en/financial/index.html">https://www.nobelpharma.co.jp/en/financ...
$CTYX Nobelpharma traces its roots back to Alfred Nobel (as in the Nobel Prize). Deep pockets involved all around. The last time Paul M Michaels brought them to the USA, they became Nobel Biocare and were bought out by Danaher Corporation. Looks like Mr. Michaels is at it again!
$CTYX take a look at Paul M Michaels background, and the caliber of corporate deals he has put together in his lifetime. Dude works with DEEP POCKETS in Pharma. Now ask yourself, would he be wasting his time with some garbage clown company?
HELL NO!!!
Nobelpharma America?!?! https://twitter.com/hustle2015/status/1249124478082330626">https://twitter.com/hustle201...
HELL NO!!!
Nobelpharma America?!?! https://twitter.com/hustle2015/status/1249124478082330626">https://twitter.com/hustle201...
$CTYX here are some links if you want to deep dive:
https://www.vbprofiles.com/people/paul-michaels-3e1429c09e597c100831a15f
https://www.vbprofiles.com/people/pa... href=" https://www.nobelpharma.co.jp/corp/about/name.html
https://www.nobelpharma.co.jp/corp/abou... href=" https://en.m.wikipedia.org/wiki/Nobel_Enterprises
https://en.m.wikipedia.org/wiki/Nobe... href=" http://wikipedia.nd.ax/wiki/Inabata_%26_Co.,_Ltd">https://wikipedia.nd.ax/wiki/Inab... (you have to add a period to the end of this link)
https://en.m.wikipedia.org/wiki/Nobel_Biocare
https://en.m.wikipedia.org/wiki/Nobe... href=" https://en.m.wikipedia.org/wiki/Danaher_Corporation
https://en.m.wikipedia.org/wiki/Dana... href=" https://en.m.wikipedia.org/wiki/AkzoNobel ">https://en.m.wikipedia.org/wiki/Akzo...
https://www.vbprofiles.com/people/paul-michaels-3e1429c09e597c100831a15f
https://www.vbprofiles.com/people/pa... href=" https://www.nobelpharma.co.jp/corp/about/name.html
https://www.nobelpharma.co.jp/corp/abou... href=" https://en.m.wikipedia.org/wiki/Nobel_Enterprises
https://en.m.wikipedia.org/wiki/Nobe... href=" http://wikipedia.nd.ax/wiki/Inabata_%26_Co.,_Ltd">https://wikipedia.nd.ax/wiki/Inab... (you have to add a period to the end of this link)
https://en.m.wikipedia.org/wiki/Nobel_Biocare
https://en.m.wikipedia.org/wiki/Nobe... href=" https://en.m.wikipedia.org/wiki/Danaher_Corporation
https://en.m.wikipedia.org/wiki/Dana... href=" https://en.m.wikipedia.org/wiki/AkzoNobel ">https://en.m.wikipedia.org/wiki/Akzo...
$CTYX the bottom line here - compare the mission statements for Connectyx and Nobelpharma America and decide for yourself:
https://www.otcmarkets.com/stock/CTYX/profile
https://www.otcmarkets.com/stock/CTY... href=" https://www.nobelpharma-us.com/ ">https://www.nobelpharma-us.com/">...
https://www.otcmarkets.com/stock/CTYX/profile
https://www.otcmarkets.com/stock/CTY... href=" https://www.nobelpharma-us.com/ ">https://www.nobelpharma-us.com/">...